Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab (OKINADA)

NCT02471118 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Adalimumab 40 mg
DRUG: Placebo

Sponsor

CARE ARTHRITIS LTD.

Collaborators

[object Object]